Impact of selective decontamination of the digestive tract on multiple organ dysfunction syndrome: Systematic review of randomized controlled trials*
Authors:
- Luciano SilvestriLSLuciano Silvestri
- Hendrick K. F. van SaeneHSHendrick K. F. van Saene
- Durk F. ZandstraDZDurk F. Zandstra
- John C. MarshallJMJohn C. Marshall
- Dario GregoriDario Gregori
- Antonino GulloAGAntonino Gullo
- 1 May 2010
- journal article
- review article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 38 (5) , 1370-1376
Abstract
We examined the impact of selective decontamination of the digestive tract on multiple organ dysfunction syndrome. We searched MEDLINE, EMBASE, the Cochrane Register of Controlled Trials, previous meta-analyses, and meetings proceedings. We included all randomized trials comparing both oropharyngeal and intestinal administration of antibiotics in selective decontamination of the digestive tract with or without a parenteral component, with placebo or standard therapy used in the controls. Two reviewers independently applied selection criteria, performed quality assessment, and extracted the data. The primary end point was the number of patients with multiple organ dysfunction syndrome developing during intensive care unit stay. Secondary end points were overall mortality and multiple organ dysfunction syndrome-related mortality. Odds ratios were pooled with the random effect model. We identified seven randomized trials including 1270 patients. Multiple organ dysfunction syndrome was found in 132 of 637 patients (20.7%) in the selective decontamination of the digestive tract group and in 219 of 633 patients (34.6%) in the control group (odds ratio, 0.50; 95% confidence interval, 0.34-0.74; p < .001). Overall mortality for selective decontamination of the digestive tract vs. control patients was 119 of 637 (18.7%) and 145 of 633 (22.9%), respectively, demonstrating a nonsignificant reduction in the odds of death (odds ratio, 0.82; 95% confidence interval, 0.51-1.32; p = .41). In five studies including 472 patients, multiple organ dysfunction syndrome-related mortality was demonstrated in 31 of 239 (13%) patients in selective decontamination of the digestive tract group and 37 of 233 (15.9%) in the controls (odds ratio, 0.84; 95% confidence interval, 0.48-1.41; p = .54). Selective decontamination of the digestive tract reduces the number of patients with multiple organ dysfunction syndrome. Mortality was not significantly reduced, probably because of the small sample size.Keywords
This publication has 43 references indexed in Scilit:
- INTESTINAL CROSSTALKShock, 2007
- Selective decontamination of the digestive tract reduces bacterial bloodstream infection and mortality in critically ill patients. Systematic review of randomized, controlled trialsJournal of Hospital Infection, 2007
- INFLUENCE OF CYCLOOXYGENASE INHIBITORS ON GUT IMMUNE CELL DISTRIBUTION AND APOPTOSIS RATE IN EXPERIMENTAL SEPSISShock, 2006
- Measuring inconsistency in meta-analysesBMJ, 2003
- Sepsis from Pseudomonas aeruginosa pneumonia decreases intestinal proliferation and induces gut epithelial cell cycle arrest*Critical Care Medicine, 2003
- Selective decontamination of the digestive tract: a life saverJournal of Hospital Infection, 2000
- Selective decontamination of the digestive tract reduces Gram-negative pulmonary colonization but not systemic endotoxemia in patients undergoing elective liver transplantationCritical Care Medicine, 1994
- Meta-analysis of randomised controlled trials of selective decontamination of the digestive tract. Selective Decontamination of the Digestive Tract Trialists' Collaborative Group.BMJ, 1993
- The Gastrointestinal Tract The “Undrained Abscess” of Multiple Organ FailureAnnals of Surgery, 1993
- The role of the gut in the development of multiple organ dysfunction in cardiothoracic patientsThe Annals of Thoracic Surgery, 1993